Hello, Guest!
  • Thursday, November 14, 2024
vaccine

GlaxoSmithKline Lands $342M Army Vaccine Procurement Contract

Pharmaceutical company GlaxoSmithKline has been awarded a $342M contract by the U.S. Army to obtain COVID-19 vaccines in mass quantities from multiple vendors.

The service branch obligated the full contract amount at the time of award to support coronavirus response efforts at military sites within and outside the continental U.S., the Department of Defense said Thursday.

Army Contracting Command received one bid for the procurement.

Contract work will take place at Research Triangle Park in North Carolina through Feb. 28, 2021.

Video of the Day

Related Articles

US Gov’t Invests $2.1B to Advance Sanofi-GSK Team’s COVID-19 Vaccine Dev’t; Alex Azar Quoted News

US Gov’t Invests $2.1B to Advance Sanofi-GSK Team’s COVID-19 Vaccine Dev’t; Alex Azar Quoted

The U.S. government has earmarked $2.1B in total funds to support the development and production of a potential COVID-19 vaccine from pharmaceutical companies Sanofi Pasteur and GlaxoSmithKline (NYSE: GSK).

Health Agencies, Biopharmaceutical Firms Form Partnership to Accelerate COVID-19 Vaccine Development News

Health Agencies, Biopharmaceutical Firms Form Partnership to Accelerate COVID-19 Vaccine Development

The National Institutes of Health and three other U.S. health agencies have teamed up with the Foundation for the NIH, European Medicines Agency and 16 biopharmaceutical companies to speed up the development of vaccines and treatments for COVID-19. The Accelerating COVID-19 Therapeutic Interventions and Vaccines partnership will work to streamline clinical trials, coordinate regulatory processes and use assets to accelerate response to the coronavirus pandemic and other future health emergencies, NIH said Friday.